Kyntra Bio KYNB
NASDAQ KYNB
$5.21 -0.14 (-2.70%)
As of: Oct 21, 2026 · 11:26 AM EDT

Kyntra Bio (KYNB) Operating Margin (2014 - 2026)

Updated

Kyntra Bio (KYNB) posted Operating Margin of -1192.27% for Q2 2026, down 298.20 percentage points from -894.07% a year earlier and down 822.60 percentage points from the prior quarter.

Analysis

Kyntra Bio (KYNB) Operating Margin (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Margin at Kyntra Bio was -665.10%, up 448.54 percentage points year-over-year; for FY2025, it came in at -712.66%, down 204.85 percentage points from FY2024.

  • Annual Operating Margin shows a five-year change of -603.83 percentage points (FY2020 to FY2025).
  • In prior years, Kyntra Bio's Operating Margin was -507.80% in FY2024 (+181.73 pp), -689.53% in FY2023 (-475.63 pp), -213.90% in FY2022 (-91.28 pp) and -122.62% in FY2021 (-13.79 pp).
  • The Q2 2026 figure stands as the lowest quarterly Operating Margin since Q3 2024.
  • On a year-over-year basis, Operating Margin increased in three of the last seven quarters, with an average year-over-year change of +300.97 percentage points.
  • The strongest year-over-year quarter for Operating Margin in the past five years was Q3 2025, with a gain of 38271.10 percentage points; the weakest was Q3 2024, with a drop of 38615.81 percentage points.
  • According to Business Quant data, Operating Margin for the three prior quarters was -369.66% (Q1 2026), -1058.10% (Q4 2025) and -502.88% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 28.21%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 37.86%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 20.57%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -133.21%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 28.37%
10 Kyntra Bio 21.09 Mn -386.85 Mn 1.47 Mn -1,192.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,192.27%
Mar 31, 2026 -369.66%
Dec 31, 2025 -1,058.10%
Sep 30, 2025 -502.88%
Jun 30, 2025 -894.07%
Mar 31, 2025 -544.72%
Dec 31, 2024 -227.53%
Sep 30, 2024 -38,773.98%
Jun 30, 2024 -4,650.10%
Mar 31, 2024 -193.90%
Sep 30, 2023 -158.18%
Jun 30, 2023 -198.67%
Mar 31, 2023 -210.42%
Dec 31, 2022 -192.49%
Sep 30, 2022 -595.21%
Jun 30, 2022 -262.44%
Mar 31, 2022 -103.56%
Dec 31, 2021 -817.51%
Sep 30, 2021 32.68%
Jun 30, 2021 -549.31%
API Access

Kyntra Bio Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=KYNB&period=max&api_key=YOUR_API_KEY